Application Sponsors
ANDA 091625 | GRANULES INDIA LTD | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 400MG | 0 | IBUPROFEN | IBUPROFEN |
002 | TABLET;ORAL | 600MG | 0 | IBUPROFEN | IBUPROFEN |
003 | TABLET;ORAL | 800MG | 0 | IBUPROFEN | IBUPROFEN |
FDA Submissions
| ORIG | 1 | AP | 2015-09-15 | |
LABELING; Labeling | SUPPL | 8 | AP | 2019-07-22 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2021-04-01 | STANDARD |
LABELING; Labeling | SUPPL | 14 | AP | 2021-04-28 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 17 |
SUPPL | 8 | Null | 7 |
SUPPL | 11 | Null | 15 |
SUPPL | 14 | Null | 7 |
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
GRANULES INDIA LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 91625
[companyName] => GRANULES INDIA LTD
[docInserts] => ["",""]
[products] => [{"drugName":"IBUPROFEN","activeIngredients":"IBUPROFEN","strength":"400MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"IBUPROFEN","activeIngredients":"IBUPROFEN","strength":"600MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"IBUPROFEN","activeIngredients":"IBUPROFEN","strength":"800MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"IBUPROFEN","submission":"IBUPROFEN","actionType":"400MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"IBUPROFEN","submission":"IBUPROFEN","actionType":"600MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"IBUPROFEN","submission":"IBUPROFEN","actionType":"800MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)